Severe Diabetic Ketoacidosis After the Second Dose of mRNA-1273 COVID-19 Vaccine

J Diabetes Sci Technol. 2022 Jan;16(1):248-249. doi: 10.1177/19322968211043552. Epub 2021 Sep 11.

Authors

Mihail Zilbermint^{1

2

3}, Andrew P Demidowich^{2

4}

Affiliations

¹ Johns Hopkins Community Physicians at Suburban Hospital, Johns Hopkins Medicine, Bethesda, MD, USA.
² Division of Endocrinology, Diabetes, and Metabolism, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
³ Johns Hopkins University Carey Business School, Baltimore, MD, USA.
⁴ Johns Hopkins Community Physicians at Howard County General Hospital, Johns Hopkins Medicine, Columbia, MD, USA.

No abstract available

Keywords: COVID-19; diabetes; diabetic ketoacidosis; vaccine.

Publication types

Letter

MeSH terms

2019-nCoV Vaccine mRNA-1273
COVID-19 Vaccines
COVID-19*
Diabetes Mellitus*
Diabetic Ketoacidosis*
Humans
SARS-CoV-2

Substances

COVID-19 Vaccines
2019-nCoV Vaccine mRNA-1273